Intrathecal nalbuphine at two doses reduces opioid use and pain after total knee arthroplasty: a randomized controlled trial
- PMID: 40779077
- DOI: 10.1007/s00590-025-04459-2
Intrathecal nalbuphine at two doses reduces opioid use and pain after total knee arthroplasty: a randomized controlled trial
Abstract
Purpose: This study aimed to assess the efficacy of different-dose intrathecal nalbuphine (ITN) in addition to adductor canal block (ACB) and its associated side effects.
Methods: This prospective randomized double-blinded controlled trial recruited 42 patients undergoing TKA at Naresuan University Hospital who received spinal anesthesia and ACB into three groups, each with 14 patients: Group A (control), Group B (additional ITN 0.8 mg), and Group C (additional ITN 1.2 mg). The primary outcome was the numeric rating scale (NRS) at rest and during movement at various time points. The secondary outcomes included the cumulative morphine use (CMU) and side effects.
Results: Forty-two patients (group A = 14; group B = 14; group C = 14) were randomized. All patients were analyzed. The group C had significantly lower NRS at rest at 6, 12, 24, and 48 h postoperatively, and significantly lower NRS during movement at 6 and 36 h postoperatively when compared to group A. There was no significant difference in NRS between group C and B, or between group B and A. The group B and C required significantly less CMU than the group A during the first 24, 48, and 72 h after TKA. The side effects, which included nausea, vomiting, drowsiness, respiratory depression, and shivering, were not significantly different among the groups.
Conclusion: Additional ITN, both 0.8 and 1.2 mg doses, effectively reduces CMU during the first 72 h after TKA. Given higher-dose ITN up to 1.2 mg provides benefit by further reducing pain scores, without increased side effects.
Trial registration clinical trials: TCTR20241012005, October 12, 2024.
Keywords: Intrathecal nalbuphine; Pain management; Postoperative nausea and vomiting; Total knee arthroplasty.
© 2025. The Author(s), under exclusive licence to Springer-Verlag France SAS, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. AI-assisted technologies was used only in the writing process to improve the readability and language of the manuscript, and it was reviewed by a native English speaker.
Similar articles
-
Is the Use of a Buprenorphine Transdermal Patch More Effective Than Oral Medications for Postoperative Analgesia After Arthroscopic Rotator Cuff Repair? A Randomized Clinical Trial.Clin Orthop Relat Res. 2025 May 1;483(5):857-865. doi: 10.1097/CORR.0000000000003303. Epub 2024 Nov 5. Clin Orthop Relat Res. 2025. PMID: 39499769 Clinical Trial.
-
Pericapsular nerve group (PENG) block compared to intrathecal morphine for analgesic efficacy in total hip arthroplasty: A placebo-controlled randomized double-blind non-inferiority trial.J Clin Anesth. 2025 Sep;106:111921. doi: 10.1016/j.jclinane.2025.111921. Epub 2025 Jul 2. J Clin Anesth. 2025. PMID: 40609218 Clinical Trial.
-
Safety and efficacy of low-dose esketamine weakly opioidized anesthesia in elderly patients with lumbar spinal stenosis undergoing surgery: a prospective, double-blind randomized controlled trial.BMC Anesthesiol. 2025 Feb 5;25(1):57. doi: 10.1186/s12871-025-02908-3. BMC Anesthesiol. 2025. PMID: 39910473 Free PMC article. Clinical Trial.
-
Femoral nerve blocks for acute postoperative pain after knee replacement surgery.Cochrane Database Syst Rev. 2014 May 13;2014(5):CD009941. doi: 10.1002/14651858.CD009941.pub2. Cochrane Database Syst Rev. 2014. PMID: 24825360 Free PMC article.
-
Nalbuphine for postoperative pain treatment in children.Cochrane Database Syst Rev. 2014 Jul 31;2014(7):CD009583. doi: 10.1002/14651858.CD009583.pub2. Cochrane Database Syst Rev. 2014. PMID: 25079857 Free PMC article.
References
-
- O’Donnell R, Dolan J (2018) Anaesthesia and analgesia for knee joint arthroplasty. BJA Educ 18(1):8–15. https://doi.org/10.1016/j.bjae.2017.11.003 - DOI - PubMed
-
- Franzoni S, Rossi SMP, Cassinadri A, Sangaletti R, Benazzo F (2023) Perioperative pain management in total knee arthroplasty: a narrative review of current multimodal analgesia protocols. Appl Sci 13(6):3798. https://doi.org/10.3390/app13063798 - DOI
-
- Memtsoudis SG, Cozowicz C, Bekeris J, Bekere D, Liu J, Soffin EM, Mariano ER, Johnson RL, Go G, Hargett MJ et al (2021) Peripheral nerve block anesthesia/analgesia for patients undergoing primary hip and knee arthroplasty: recommendations from the International Consensus on Anesthesia-Related Outcomes after Surgery (ICAROS) group based on a systematic review and meta-analysis of current literature. Reg Anesth Pain Med 46:971–985. https://doi.org/10.1136/rapm-2021-102750 - DOI - PubMed
-
- Fillingham YA, Hannon CP, Kopp SL, Austin MS, Sershon RA, Stronach BM et al (2022) The efficacy and safety of regional nerve blocks in total knee arthroplasty: systematic review and direct meta-analysis. J Arthroplasty 37(10):1906–1921. https://doi.org/10.1016/j.arth.2022.03.078 - DOI - PubMed
-
- Lavand’homme PM, Kehlet H, Rawal N, Joshi GP (2022) Pain management after total knee arthroplasty: PROcedure SPEcific postoperative pain managemenT recommendations. Eur J Anaesthesiol 39(9):743–757. https://doi.org/10.1097/EJA.0000000000001691 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical